Warby Parker Inc. revenue by segment WRBY

Annual Quarterly

Warby Parker Inc. splits its revenue into 5 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Eyewear Products at $719.1 million, 82% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2026 Sep 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021
Revenue	935	872	771	670	598	541
Eyewear Products	—	719 +10.3% share 82.5%	652 +11.8% share 84.5%	583 +2.5% share 87.1%	569 +8.8% share 95.1%	523 share 96.7%
Contacts Products	—	97 +23.4% share 11.1%	79 +36.0% share 10.2%	58 share 8.6%	—	—
Eye Care	—	56 +37.5% share 6.4%	41 +41.3% share 5.3%	29 -2.4% share 4.3%	29 +64.7% share 4.9%	18 share 3.3%
Shipping And Handling	—	4 -2.6% share 0.4%	4 -5.0% share 0.5%	4 -2.4% share 0.6%	4 +46.4% share 0.7%	3 share 0.5%
Gift Card	—	—	—	—	—	0 share 0.0%

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Ophthalmic Goods (SIC 3851)
Listed as: WRBY (NYSE)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: New York, NY
SEC filer status: Large accelerated filer
SEC CIK: 1504776
Former names: JAND, Inc. (until Mar 23, 2018)

Other Ophthalmic Goods companies

All 8 Ophthalmic Goods companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.